Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Comparing different limb lengths in gastric bypass surgery for weight loss

Official title: Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)

Run by The Cleveland Clinic · NCT06293703 · Data updated 2026-11-12

This study is testing if adjusting the lengths of parts of gastric bypass surgery can help morbidly obese patients lose more weight and improve health issues like diabetes and high blood pressure compared to standard surgery.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment262 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedJanuary 12, 2024
Main results expectedDecember 11, 2030
Study endsDecember 11, 2030
Registry record updatedMarch 20, 2026
Trial IDNCT06293703 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are morbidly obese individuals with a BMI between 40 and 60 who are willing to commit to long-term follow-up.

Probably not a fit

Patients with a history of previous bariatric surgery, severe unrelated health conditions, or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of limb length ratios in Roux-en-Y gastric bypass surgery on weight loss and metabolic outcomes in morbidly obese patients. Participants will be randomly assigned to receive either standard fixed-length gastric bypass or a ratio-adjusted version that customizes limb lengths based on the patient's total small bowel length. The study aims to determine if the ratio-adjusted approach leads to greater total weight loss and improved resolution of metabolic syndrome comorbidities, such as diabetes and hypertension. Quality of life metrics will also be assessed postoperatively using the SF36 survey.

Why it matters

Potential benefit: If successful, this study could lead to more effective gastric bypass procedures that enhance weight loss and improve metabolic health in morbidly obese patients.

How similar studies have gone: While there have been studies on gastric bypass techniques, this specific approach of using ratio-adjusted limb lengths is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* morbidly obese patients (defined by BMI between 40 and 60).
* Patient who understands and accepts the need for a long-term follow-up.
* Patient who agrees to be included in the study

Exclusion Criteria:

* individuals unable to understand and sign a written consent form
* patients with history of previous bariatric surgery procedures
* presence of a severe and evolutive life threatening pathology unrelated to obesity
* previous gastric or small bowel resection
* active cancer
* pregnancy or desired to be pregnant during the study
* mentally unbalanced patients under supervision or guardianship, patient unable to give consent

Where it's running

  • Cleveland clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: Salvador Navarrete, MD — The Cleveland Clinic
  • Study coordinator: Salvador Navarrete, MD
  • Email: navarrs@ccf.org
  • Phone: 2162199211

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.